2-amino-5,6-dihydro-6-methyl-4h-1,3-thiazine has been researched along with Cardiac Hypertrophy in 1 studies
2-amino-5,6-dihydro-6-methyl-4H-1,3-thiazine: a selective inhibitor of nitric oxide synthase; structure given in first source
Cardiac Hypertrophy: Enlargement of the HEART due to chamber HYPERTROPHY, an increase in wall thickness without an increase in the number of cells (MYOCYTES, CARDIAC). It is the result of increase in myocyte size, mitochondrial and myofibrillar mass, as well as changes in extracellular matrix.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, K | 1 |
| Tokumura, M | 1 |
| Ito, T | 1 |
| Murai, T | 1 |
| Takashima, A | 1 |
| Ibii, N | 1 |
1 other study available for 2-amino-5,6-dihydro-6-methyl-4h-1,3-thiazine and Cardiac Hypertrophy
| Article | Year |
|---|---|
Involvement of iNOS in postischemic heart dysfunction of stroke-prone spontaneously hypertensive rats.
Topics: Animals; Cardiomegaly; Coronary Circulation; Coronary Disease; Enzyme Inhibitors; Fetal Blood; Gene | 2001 |